Valion Bio Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Valion Bio Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- VBIO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001787740
Board of directors
-
Christina Rizopoulos Valauri · DirectorSince 2024
-
Dean Zikria · DirectorSince 2023
-
Jennifer Ernst · Director · Chief Executive OfficerSince 2023
-
Karen Drexler · DirectorSince 2023
-
Michael K. Handley · Director · Chief Executive OfficerSince 2026
-
Sheryle Bolton · DirectorSince 2023
Chief executives
Jennifer Ernst
· Chief Executive Officer
Dates unknown
Michael K. Handley
· Chief Executive Officer
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via Karen Drexler
- via Christina Rizopoulos Valauri
- via Karen Drexler
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $28,450
- 2 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Wolf Lisa G Officer (Chief Financial Officer) | Option exercise | +92 | — | — |
| May 18, 2026 | Michael K. Handley Director, Officer (Chief Executive Officer) | Option exercise | +2,206 | — | — |
| Apr 15, 2026 | Sheryle Bolton Director | Open-market purchase | +10,000 | $1.04 | $10,400 |
| Apr 1, 2026 | Christina Rizopoulos Valauri Director | Open-market purchase | +19,000 | $0.95 | $18,050 |
| Mar 18, 2026 | Wolf Lisa G Officer (Chief Financial Officer) | Option exercise | +92 | — | — |
| Feb 18, 2026 | Handley Michael K Officer (Chief Operating Officer) | Option exercise | +8,824 | — | — |
| Dec 18, 2025 | Wolf Lisa G Officer (Chief Financial Officer) | Option exercise | +736 | — | — |
| Dec 18, 2025 | Jennifer Ernst Director, Officer (Chief Executive Officer) | Option exercise | +14,706 | — | — |
| Dec 18, 2025 | Wolf Lisa G Officer (Chief Financial Officer) | Shares withheld for tax | −302 | $1.87 | $565 |
| Dec 18, 2025 | Jennifer Ernst Director, Officer (Chief Executive Officer) | Shares withheld for tax | −5,262 | $1.87 | $9,840 |
| Sep 22, 2025 | Jennifer Ernst Director, Officer (Chief Executive Officer) | Grant or award | +22,541 | — | — |
| Mar 12, 2024 | Bambach Kimberly Ann Officer (Interim CFO) | Grant or award | +7,500 | — | — |
| May 16, 2022 | Karen Drexler Director | Other | −15,111 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.